NANOPARTICLES-BASED DELIVERY SYSTEMS: TYPES AND PROPERTIES
Delivery technologies represent an important
broader part of science, which engages multidisciplinary methodical
improvement. Usually, delivery systems are associated with a carrier. In
nanoparticle based delivery systems, the active compound is dissolved or
entrapped or encapsulated in the carrier; in addition, the active compound
could be adsorbed or attached to the nanoparticle (11). Often the drug is
attached with the nanosphere and encapsulated in nanocapsule (Figure 1). There
are several advantages of nanoparticles as delivery
systems. First, the particle size, particle morphology and surface charge of nanoparticles can be easily controlled (12). Second, controlled and sustained discharge of the active molecule in the time of the delivery and at the location of localization. Third, particle degradation properties can change with a modified carrier. Lastly, the site-specific delivery can be carried out in nanoparticle based delivery systems that can be used for various routes of drug deliveries like oral, nasal, parenteral, etc. Based on the importance, the development of nanoparticle based delivery systems is rapidly growing using proteins, natural polymers, synthetic polymers, and fullerenes.
systems. First, the particle size, particle morphology and surface charge of nanoparticles can be easily controlled (12). Second, controlled and sustained discharge of the active molecule in the time of the delivery and at the location of localization. Third, particle degradation properties can change with a modified carrier. Lastly, the site-specific delivery can be carried out in nanoparticle based delivery systems that can be used for various routes of drug deliveries like oral, nasal, parenteral, etc. Based on the importance, the development of nanoparticle based delivery systems is rapidly growing using proteins, natural polymers, synthetic polymers, and fullerenes.
3.1. Protein based delivery
systems
Several nano-sized protein based delivery
systems are available (Figure 2A). Albumin, gelatin, gliadin and legumin are the protein based nanoparticles which
play a vital role in drug delivery. Among these proteins, albumin, gelatin are animal based; gliadin and legumin
are plant based.
3.1.1. Albumin
Albumin is a versatile
protein carrier, and extensively used to construct nanospheres and nanocapsules
(13). Albumin is a plasma protein which
is well accepted due to its harmless in nature such as non-hazardous,
non-immunogenic, biocompatible and biodegradable nature (14). Several
nanotechnological methodologies such as desolvation, emulsification, thermal gelation,
nano-spray drying and self-assembly are used quite often for fabrication of
albumin nanoparticles especially from bovine serum albumin (BSA) as well as human serum albumin (HSA) (15,16).
Albumin carries different reactive groups such as thiol, amino, and carboxylic
groups. These groups can be applied for ligand binding or other surface
alterations. Albumin has a tendency to accumulate on solid tumors (17) and
therefore, this property has been explored for site-specific delivery of
anti-tumor drugs. For example, noscapine, a
benzylisoquinoline alkaloid from plants of the papaveraceae family has been
recently delivered to tumor cells to see its efficacy as anticancer agent using
HSA nanoparticle carrier. Here, optimal ranges (150-300 nm)
of HSA nanoparticle size and drug-loading effectiveness (85%-96%) have
been achieved (18). Therefore, albumin nanoparticle is particularly useful for
efficient delivery of chemical and pharmaceutical active ingredients.
3.1.2. Gelatin
Gelatin comes from collagen which is
a fundamental component of animal skin, bones or connective tissue and used in
the production of nanoparticle delivery systems. Stringy collagen, an insoluble
protein, is hydrolyzed to prepare gelatin (19). It is a biodegradable and
non-toxic nanoparticle that is easy to crosslink (20). As such, there is an
enormous scope for the research of colloidal drug delivery using gelatin (21, 22). Gelatin molecule
contains amino acids such as glycine, proline and alanine; and these amino
acids are accountable for the helical arrangement especially triple helical
structure of this molecule (23). Sometimes, chemical modifications can be
performed in the process of preparing the nanoparticles for the development of
a drug delivery system (24).
Recently, a study by Lee et al. (25) loaded three dissimilar drugs
(tizanidine hydrochloride, gatifloxacin and fluconazole) in gelatin
nanoparticles. This group reported that gelatin nanoparticle filled with
tizanidine hydrochloride, blank nanoparticles and gatifloxacin- filled nanoparticles, under crosslinked situation, 59.3, 23.1
and 10.6% yield of drug loaded gelatin. In another study
by Zhao et
al. (26), they used gelatin nanoparticles with insulin used for diabetes
treatment through pulmonary administration. These findings reflect the better
bioavailability, speedy and stable hypoglycemic outcome. Several reports on the
applications of gelatin nanoparticle based drug delivery systems include ocular
delivery (27), anticancer drug delivery (28), etc. In gelatin drug delivery
system, the outer of layer gelatin capsule (hard and soft ) has a tendency to
form inter or intra-molecular cross-link
that is dependent on time, temperature and humidity; because of this trend, the
use of gelatin in pharmaceutical formulations is debated (29).
3.1.3. Gliadin
Gliadin, a plant based protein, is
suitable for the construction of mucoadhesive nanoparticles. It can be
extracted from wheat and vicillin (30). Based on the natural origin,
biodegradability, and biocompatibility, this nanoparticle is used in various
drug deliveries. This drug delivery is used for controlled release of
pharmaceutical ingredients (31). To evaluate its bioadhesive properties,
gliadin nanoparticle was added to carbazole in two forms i.e. non-hardened
gliadin nanoparticles (NPs) as well as cross-linked gliadin nanoparticles
(CL-NP). Both of these nanoparticles showed a good absorption at the upper
gastrointestinal regions, especially in the stomach mucosa (32). When gliadin
nanoparticles were used for the oral delivery of tetanus toxoid, the results
showed 50% w/w antigen stability over 3 weeks of testing (33). Thus, it has
greater potential for the delivery of active molecules in targeted therapy of
upper gastrointestinal tract and possibly for other targeted delivery systems.
3.1.4. Legumin
Legumin is a protein from pea and a source of
sulfur-containing amino acids. Legumin-based nanoparticle delivery systems can
be made following aggregation and chemical cross-linkage with glutaraldehyde
(34). Irache et al. (35) prepared
legumin nanoparticles of approximately 250 nm diameter using the
pH-coacervation method and chemical cross-linking with glutaraldehyde. However,
one study with legumin immunized rats robustly
expressed antibodies against this protein. This may be due to the reduction of
antigenic epitopes of is protein bring on the glutaraldehyde employed
throughout the cross-linking (34).
3.2. Natural polymers and
their derivates
Nanoparticle based delivery systems can be
prepared from different natural materials. Chitosan, dextran, starch, liposome etc. are such nanoparticle based drug delivery systems.
3.2.1. Chitosan
Chitosan, is a structural part within
exoskeleton of subphylum crustaceans, can be formed
commercially by deacetylation (36). It is biodegradable, safe, biocompatible,
easily modified, no difficulty for DNA or protein composite formation,
widespread accessibility, and low-priced which makes the chitosan a promising
delivery system. It is of natural origin making it well accepted for the
biological applications. Chitosan, a mucoadhesive polymer increases the
cellular permeability, improves the bioavailability of orally delivered protein
based drugs (37) and boosts the protein uptake (38-41). Oral delivery of
chitosan DNA nanoparticles was examined for vaccine delivery and seems to be
useful for inducing immune system against Toxoplasma
gondii (42).
3.2.2. Dextran
Dextran is a complex, polysaccharide of
D-glucose monomers linked by glycosidic bonds (43). Magnetite dextran
nanoparticles can be developed from dextran. These
particles have null zeta potential which contributes to high safety margin and
efficacy (44). Presently, this polysaccharide nanoparticle is used as drug
carrier system (45) in tumor targeted delivery (46), oral delivery of insulin
(47), reticuloendothelial delivery (48) etc. It has been reported that
chitosan-carboxymethyl dextran nanoparticles regulate cell proliferation and
serum cytokine (49).
2.2.3. Starch
Starch is a natural polymer found in grains of
plants like rice, corn, wheat, tapioca, potato etc. It is biodegradable and abundant biomass
material in nature (50, 51). Nanocrystal (52), nanoparticles (53) and
nanocolloids (54) were prepared from the starch. Several researchers
have used starch as a drug delivery system. Cross-linked starch nanoparticles
with hydrophobic end were used for drug delivery of indomethacin (55). Starch
has been used as drug delivery system for tumor-targeted drug delivery (56),
trans-dermal drug delivery (57) and brain tumor-targeted drug delivery (58). A
starch microsphere is utilized as drug delivery for tissue engineering. This
starch microsphere further loaded with definite growth factors and immobilized,
and can be employed for delivery of encapsulate living cells (59).
3.2.4. Liposome
Liposome, made of lipid bilayer, is an extensively explored
drug delivery system. Its diameter varies from 20 nm to more than a few
hundreds of nanometers and width of the phospholipid bilayer is about 4–7 nm
(60). Liposomes can be classified into three forms such as multilamellar
vesicles (MLV), small
unilamellar vesicles (SUV) and
large unilamellar vesicles (LUV). MLV
consists of a number of concentric bilayers in a particle and the diameter of
this liposome may differ from
hundred to thousands of nanometers. MLVs can be processed to produce
unilamellar vesicles. According to size, unilamellar vesicles can be classified
into two types such as small unilamellar vesicles (SUV) and large unilamellar
vesicles (LUV). SUVs show a diameter lower than 100 nm, while LUVs have
diameter bigger than 100 nm (61-63). In addition, there were several reports
indicating the application of liposomes as dyes in textiles (64), pesticides
for plants (65), food
ingredients (66) and cosmetics to the skin (67) in areas other than drug
delivery systems. Several drugs are in clinical
trials, which use liposomal delivery systems (68). However, for targeted cancer drug and
therapeutic protein delivery, liposome constructed with PEG (Polyethylene
Glycol) is one of the sought after preferences for the delivery. It can
increase the plasma stability and solubility property of the drug. Conversely,
this increase properties help to decrease its immunogenicity and now PEGylated
drugs in clinical practice. One example
of PEGylated drug is Oncaspar (PEG–L-asparaginase) which familiar to treat
acute lymphoblastic leukemia (68).
3.3. Polymeric carriers
Several polymer based carriers are available
(Figure 2C) such as polylactic acid, block copolymers, polyethyleinemine, etc.
These polymer carriers are significant in drug delivery systems.
3.3.1. Polylactic acid
Polylactic acid (PLA),
thermoplastic
aliphatic polyester, is promising biodegradable polyester (79). PLA is a member
of the family of aliphatic polyesters. This family usually composed of α
-hydroxy acids. Polylactic acid nanoparticles are used as colloidal drug
delivery system for lipophilic drugs (70). This type of delivery system is
regularly used for the cancer related drug delivery (71, 72). For example,
PEG-coated polylactic acid nanoparticle was used for the delivery of
Hexadecafluoro zinc phthalocyanine (ZnPcF16) for the mammary tumor therapy
(71). Another example, cucurbitacin, was delivered using polylactic acid
nanoparticles to oral cancer (72). Recently, PLA is used for the Plasmid DNA delivery. These results showed lower cytotoxicity
compare to Lipofectamine 2000. PLA can transfer gene into HELA cells. From this
we conclude that PLA can be a
promising non-viral nano-device for cancer gene therapy (73).
3.3.2. Block copolymers
Block copolymers, a type of copolymer, is made
up of different polymerized monomers (74). Amphiphilic block copolymers
encompass the capacity to bring together into multiple morphologies in solution
(75). However, vesicle configuration of
amphiphilic block copolymers depends on raise in total molecular weight and
increasing bending modulus (K). A vesicular morphology is applicable in
the fields of drug delivery (76). Amphiphilic linear-dendritic block copolymers (LDBC)
have been developed for drug
delivery (77).
Further, synthesized LDBC was established to be a candidate for drug delivery
due to some important characteristics such as relative stability, drug
encapsulation and release property (78). In
vitro release behavior of LDBC can be controlled by light which is a potential
carrier for controlled drug delivery (79).
Recently, biodegradable amphiphilic copolymer was used for cancer drug delivery
(80, 81). Eg. Block copolymer COPY-DOX
showed high anticancer efficacy in the course of
some biochemical test such as MTT assays against cancer cells (80).
3.3.3. Polyethyleinemine
Polyethyleneimine, containing secondary amines, is a
biodegradable polymer and widely used in the cell culture
for the attachment of weakly anchoring cells (82). It is insoluble in cold
water, benzene, etc. This polymer includes primary, secondary, and tertiary
amino groups. Polyethyleneimine is also used in gene
delivery (83, 84) and gene therapy
(85). It is also used for drug delivery
(86) especially to cross the blood-brain barrier (87). Extreme cytotoxic effect prevents its use from
drug delivery (88).
3.4. Dendrimers
Dendrimers are branched polymers, presently
used a significant drug carrier system (Figure 2D). Poly (amidoamine) spherical
dendrimers, poly (Propylene Imine) dendrimers are similar
type of nanoparticle.
3.4.1. Poly (amidoamine)
spherical dendrimers (PAMAM)
Poly (amidoamine), is one of the well known
dendrimers which conatin a diamine. This is commonly used in analytical
chemistry in the separation science (89-91). These molecules are used in gene
delivery (92). Gamma-Glutamyl PAMAM dendrimers are used as versatile precursor
for dendrimer-based delivery of active pharmaceuticals
(93).
3.4.1. Poly
(propylene imine) dendrimers (PPI)
During the last few years, poly (propylene imine) dendrimers (regularly branched molecules) is
popular due to their unique physical properties. Poly (propylene imine)
dendrimers are the preeminent surveyed dendrimer systems (94-97). Numerous
hybrid dendrimers have been prepared with different end groups with distinctive
characters (97-100). Multifunctional dendrimeric systems derived from poly
(propylene imine) dendrimers are used as targeted drug delivery systems to
encapsulate the drug (101). In a study, antimicrobial activity was analyzed
using this delivery system against Bacillus subtilis, Staphylococcus aureus and
Escheriachia coli where exceptional inhibition capacity was reported against
these bacteria. They used with silver nanoparticles as antimicrobial drug
(102). Dendrimer is toxic
due to its positively charged exterior part. However, this toxicity can be
reduced by putting an outside layer these peripheral cationic groups with
carbohydrate residues (103).
3.5. Fullerene
Fullerene, a hollow sphere or tube composed of carbon, can be
used as a drug delivery system (Figure 2E). Buckyball clusters are examples of fullerene which have been studied for drug
delivery.
3.5.1. Buckyball clusters
Buckyball clusters have hexagons and pentagons
linked jointly in a coordinated manner and can develop a hollow ground with
bonding strains composed entirely of carbon. All these molecules are used in
delivery systems particularly for drugs (104,105).
3.6. Carbon nanotubes (CNTs)
Carbon
nanotubes, covalently bonded fullerenes, are used as molecular anchors (106).
These fullerenes have bigger inner volume which can be used as the active
molecule container. Therefore, several molecules can be attached with this
carrier which is readily taken up by the cell (107). CNTs are used in the drug delivery of several molecules, especially for cancer
drugs (108,109). These can be applied as biological transporters as well
an agent for some cancer cell destruction (108). In vivo distribution and tumor targeting of CNTs have been studied
(109). Concerns about CNTs that prevents advancement in its drug delivery
applications include lack of solubility, clumping and aggregation and 6.8h
half-life (110). However, studies
have demonstrated that functionalized CNTs are non-cytotoxic (111). CNT has fibrous contour which is needle-like and toxic
property has been related with asbestos. One of the major concerns is that
extensive application of CNT may lead to cancer especially lung cancer (253). However,
to avoid excessive surface interactions, CNT can be used as nanocapsules shown
its biocompatibility for intravenous drug delivery (254).
Post Comment
No comments